Thrombocytopenia in medical-surgical critically ill patients: Prevalence, incidence, and risk factors

Journal of Critical Care

Volumn 20, Issue 4, 2005, Pages 348-353

  Crowther, Mark A ^a   Cook, Deborah J ^a   Meade, Maureen O ^a   Griffith, Lauren E ^a   Guyatt, Gordon H ^a   Arnold, Donald M ^a   Rabbat, Christian G ^a   Geerts, William H ^a   Warkentin, Theodore E ^a  

^a NONE

Author keywords

Critical care; Deep venous thrombosis; Incidence; Prevalence; Risk factors; Venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; HYPERTENSIVE AGENT; INOTROPIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIALYSIS; DISEASE SEVERITY; ECHOGRAPHY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INJURY; INTENSIVE CARE UNIT; LEG; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORTHOPEDIC SURGERY; PATIENT SELECTION; PREGNANCY; PREVALENCE; RISK FACTOR; SURGICAL PATIENT; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

AGED; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; ONTARIO; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 28444473911     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2005.09.008     Document Type: Conference Paper

References (23)

1. R.P. Baughman, E.E. Lower, H.C. Flessa, and D.J. Tollerud Thrombocytopenia in the intensive care unit Chest 104 4 1993 1243 1247
2. M.F. Bonfiglio, S.M. Traeger, K.L. Kier, B.R. Martin, D.T. Hulisz, and S.R. Verbeck Thrombocytopenia in intensive care patients: a comprehensive analysis of risk factors in 314 patients Ann Pharmacother 29 9 1995 835 842
3. F. Stephan, J. Montblanc, A. Cheffi, and F. Bonnet Thrombocytopenia in critically ill surgical patients: a case-control study evaluating attributable mortality and transfusion requirements Crit Care 3 6 1999 151 158
4. S. Vanderschueren, W.A. De, M. Malbrain, D. Vankersschaever, E. Frans, and A. Wilmer Thrombocytopenia and prognosis in intensive care Crit Care Med 28 6 2000 1871 1876
5. R. Strauss, M. Wehler, K. Mehler, D. Kreutzer, C. Koebnick, and E.G. Hahn Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome Crit Care Med 30 8 2002 1765 1771
6. R.E. Drews Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients Clin Chest Med 24 4 2003 607 622
7. R.E. Drews, and S.E. Weinberger Thrombocytopenic disorders in critically ill patients Am J Respir Crit Care Med 162 2 Pt 1 2000 347 351
8. G.E. Garber, N. Gibney, B. Light, C. Martin, K. Cunningham, and J.C. Guimod Guidance on patient identification and administration of recombinant human activated protein C for the treatment of severe sepsis Can J Infect Dis 13 6 2002 361 372
9. D.J. Cook, M.A. Crowther, M. Meade, C. Rabbat, D. Schiff, and W. Geerts Deep vein thrombosis in medical-surgical ICU patients: prevalence, incidence and risk factors Crit Care Med 33 7 2005 1477 1488
10. B.D. Spiess, D. Royston, J.H. Levy, J. Fitch, W. Dietrich, and S. Body Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes Transfusion 44 8 2004 1143 1148
11. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACE II: a severity of disease classification system Crit Care Med 13 10 1985 818 825
12. J.C. Marshall, D.J. Cook, N.V. Christou, G.R. Bernard, and C.L. Sprung Multiple Organ Dysfunction Score: a reliable descriptor of a complex clinical outcome Crit Care Med 23 10 1995 1638 1653
13. T.E. Warkentin, J.A. Sheppard, P. Horsewood, P.J. Simpson, J.C. Moore, and J.G. Kelton Impact of the patient population on the risk for heparin-induced thrombocytopenia Blood 96 5 2000 1703 1708
14. T.E. Warkentin, J.I. Sheppard, J.C. Moore, K.M. Moore, C.S. Sigouin, and J.G. Kelton Laboratory testing for HIT antibodies: how much class do we need? Blood 104 2004 825a [Ref Type: Abstract]
15. P. Horsewood, T.E. Warkentin, C.P. Hayward, and J.G. Kelton The epitope specificity of heparin-induced thrombocytopenia Br J Haematol 95 1 1996 161 167
16. D.R. Cox Regression models and life tables J R Stat Soc 34 1972 187 220
17. N. Zytaruk, F. Clarke, E. McDonald, M. Meade, L. Griffith, and G.H. Guyatt Heparin-induced thrombocytopenia in medical-surgical ICU patients Crit Care Med 31 12 2004 A73 [Ref Type: Abstract]
18. S. Akca, P. Haji-Michael, M.A. De, P. Suter, M. Levi, and J.L. Vincent Time course of platelet counts in critically ill patients Crit Care Med 30 4 2002 753 756
19. S.J. Shalansky, A.K. Verma, M. Levine, J.J. Spinelli, and P.M. Dodek Risk markers for thrombocytopenia in critically ill patients: a prospective analysis Pharmacotherapy 22 7 2002 803 813
20. F. Stephan, J. Hollande, O. Richard, A. Cheffi, M. Maier-Redelsperger, and A. Flahault Thrombocytopenia in a surgical ICU Chest 115 5 1999 1363 1370
21. R.A. Baughman, S.C. Kapoor, R.K. Agarwal, J. Kisicki, F. Catella-Lawson, and G.A. Fitzgerald Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans Circulation 98 16 1998 1610 1615
22. A.K. Verma, M. Levine, S.J. Shalansky, C.J. Carter, and J.G. Kelton Frequency of heparin-induced thrombocytopenia in critical care patients Pharmacotherapy 23 2003 745 753
23. T.E. Warkentin, and A. Greinacher Heparin-induced thrombocytopenia: recognition, treatment and prevention Chest 126 3S 2004 311S 337S